We are live on
!
Find out more
LNAI
Lunai Bioworks
LNAI
LNAI
43 hedge funds and large institutions have $21.5M invested in Lunai Bioworks in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
800% more call options, than puts
Call options by funds: $234K | Put options by funds: $26K
19% more capital invested
Capital invested by funds: $18M → $21.5M (+$3.48M)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0% more ownership
Funds ownership: 0.06% → 0.06% (+0%)
2% less funds holding
Funds holding: 44 → 43 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
13
Closed
10
Calls
$234K
Puts
$26K
Net Calls
+$208K
Net Calls Change
+$84K
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$1.41M |
| 2 |
Millennium Management
New York
|
+$814K |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$250K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$242K |
| 5 |
Jane Street
New York
|
+$158K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$659K |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
-$572K |
| 3 |
Morgan Stanley
New York
|
-$554K |
| 4 |
D.E. Shaw & Co
New York
|
-$405K |
| 5 |
AGM
Alpine Global Management
New York
|
-$177K |
